The Incidental Renal Mass: Observation, Ablation, or Surgery (C)
This session has been identified and designated as Credit to Meet ACS Accreditation/Verification Requirements for Cancer.
Greater use of imaging has led to a corresponding rise in the detection of renal incidentalomas and left many urologists and non-urologists alike unsure of what to do about the masses they have found. One-third of individuals age fifty and older will have at least one renal cyst on computed tomography (CT). Most incidental renal masses are benign cysts requiring no further evaluation. Other possibilities include indeterminate cysts or solid masses, which may be malignant or benign. The Panel Session will review the evaluation and workup of incidental renal masses as well as surveillance recommendations, and management strategies including observation, ablation, and surgery. The target audience will include all those who perform cross sectional abdominal imaging on patients for other benign or malignant conditions or evaluations.
- Introduction to the Incidental Renal Mass
Alexander Kutikov, MD, FACS, Philadelphia, PA
- Epidemiology and Natural History of Small Incidental Renal Masses
Hung-Jui Tan, MD, Durham, NC
- The Role of Active Surveillance and Biopsy in the Management of Small Incidental Renal Masses
Marc Smaldone, MD, FACS, Rockledge, PA
- Surgical Considerations for the Non-Urologic Surgeons
Viraj Master, MD, FACS, Atlanta, GA
- Management Approaches and Cost for Incidental Renal Masses
Steven L. Chang, MD, FACS, Boston, MA
- Practicing surgeons
- Apply new knowledge and ideas to improve their surgical practice
- Adapt concepts and quality measures in support of research advancements
- Enhance the quality of patient care
- For questions about the course content, please contact firstname.lastname@example.org.
- If you have any technical questions, contact email@example.com.
In accordance with the ACCME Accreditation Criteria, the American College of Surgeons must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all relevant financial relationships with any commercial interest. For additional information, please visit the ACCME website: http://www.accme.org/requirements/accreditation-requirements-cme-providers/policies-and-definitions/financial-relationships-and-conflicts-interest
The ACCME also requires that ACS manage any reported conflict and eliminate the potential for bias during the educational activity. Any conflicts noted below have been managed to our satisfaction. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during a activity, please report it on the evaluation.
(Download the full list of disclosures.)
Faculty and Disclosures
Hung-Jui Tan, MD, Durham, NC - No Disclosures
Marc Smaldone, MD, FACS, Rockledge, PA - No Disclosures
Viraj Master, MD, FACS, Atlanta, GA - No Disclosures
Steven L. Chang, MD, FACS, Boston, MA -Pfizer,Argos,Janssen: Honoraria: Advisory Board
Program Committee and Disclosures
CHAIR: Henri R. Ford, MD, MHA, FACS, FAAP, FRCSEng(Hon), Miami, FL - No Disclosures
VICE-CHAIR: David T. Cooke, MD, FACS, Sacramento, CA - No Disclosures
David C. Borgstrom, MD, FACS, Morgantown, WV - No Disclosures
Daniel L. Dent, MD, FACS, San Antonio, TX - No Disclosures
Roger R. Dmochowski, MD, FACS, Nashville, TN - Allergen: Honoraria: Consultant
Audra A. Duncan, MD, FACS, London, ON - No Disclosures
Mariam F. Eskander, MD, Boston, MA - No Disclosures
Paula Ferrada, MD, FACS, Richmond, VA - No Disclosures
Neil H. Hyman, MD, FACS, Chicago, IL - No Disclosures
Martin S. Karpeh, Jr., MD, FACS, New York, NY - No Disclosures
Dennis H. Kraus, MD, FACS, New York, NY - No Disclosures
Kenneth W. Sharp, MD, FACS, Nashville, TN - No Disclosures
David A. Spain, MD, FACS, Stanford, CA - No Disclosures
Mary T. Hawn, MD, FACS, Stanford, CA - No Disclosures
Daniel M. Herron, MD, FACS, FASBMS, New York, NY - No Disclosures
Barbara Lee Bass, MD, FACS, FRCS(Hon), Houston, TX - No Disclosures
Quan-Yang Duh, MD, FACS, San Francisco, CA - No Disclosures
B. J. Hancock, MD, FACS, FRCSC, Winnipeg, MB - No Disclosures
Ronald V. Maier, MD, FACS, FRCSEd(Hon), Seattle, WA - No Disclosures
Valerie W. Rusch, MD, FACS, New York, NY - No Disclosures
Continuing Medical Education Credit Information
The American College of Surgeons is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA PRA Category 1 Credits™
The American College of Surgeons designates this enduring activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Of the AMA PRA Category 1 Credits™ listed above, a maximum of 1.5 credits meets the requirements for Self-Assessment.
Note: Residents will receive a Certificate of Completion.
- 1.50 AMA PRA Category 1 Credit™
- 1.50 Certificate of Completion
- 1.50 Self Assessment Credit